Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis.

J Clin Oncol. 2021 Jan 10;39(2):136-144.

Více informací ZDE 

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.

Radiother Oncol. 2021 Jan 27;156:281-293.

Více informací ZDE 

Breast Cancer Molecular Subtype as a Predictor of Radiation Therapy Fractionation Sensitivity.

Int J Radiat Oncol Biol Phys. 2021 Jan 1;109(1):281-287.

Více informací ZDE 

Definitive radiotherapy for prostate cancer in Norway 2006-2015: Temporal trends, performance and survival.

Radiother Oncol. 2021 Feb;155:33-41.

Více informací ZDE 

Patient-reported functional outcomes following external beam radiation therapy for prostate cancer with and without a high-dose rate brachytherapy boost: A national population-based study.

Radiother Oncol. 2021 Feb;155:48-55.

Více informací ZDE 

The impact of stereotactic body radiation therapy on the overall survival of patients diagnosed with early-stage non-small cell lung cancer.

Radiother Oncol. 2021 Feb;155:254-260.

Více informací ZDE 

Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) - An analysis of UK's largest cohort of lung SABR patients.

Radiother Oncol. 2021 Mar;156:153-159.

Více informací ZDE 

Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factors.

Radiother Oncol. 2021 Mar;156:201-208.

Více informací ZDE 

1